259 related articles for article (PubMed ID: 29967250)
21. Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas.
Wong NA; Herbst H; Herrmann K; Kirchner T; Krajewski AS; Moorghen M; Niedobitek F; Rooney N; Shepherd NA; Niedobitek G
J Pathol; 2003 Oct; 201(2):312-8. PubMed ID: 14517849
[TBL] [Abstract][Full Text] [Related]
22. Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.
Carethers JM; Jung BH
Gastroenterology; 2015 Oct; 149(5):1177-1190.e3. PubMed ID: 26216840
[TBL] [Abstract][Full Text] [Related]
23. Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis.
Galandiuk S; Rodriguez-Justo M; Jeffery R; Nicholson AM; Cheng Y; Oukrif D; Elia G; Leedham SJ; McDonald SA; Wright NA; Graham TA
Gastroenterology; 2012 Apr; 142(4):855-864.e8. PubMed ID: 22178590
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer.
Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM
Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042
[TBL] [Abstract][Full Text] [Related]
25. Pathologic features of colorectal carcinomas associated with Crohn's disease in Korean population.
Kim J; Lee HS; Park SH; Yang SK; Ye BD; Yang DH; Kim KJ; Byeon JS; Yoon YS; Yu CS; Kim J
Pathol Res Pract; 2017 Mar; 213(3):250-255. PubMed ID: 28214210
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer in colonic Crohn's disease--high frequency of DNA-aneuploidy.
Sjöqvist U; Befrits R; Söderlund S; Ost A; Karlén P; Tribukait B; Rubio C; Rutgeerts P; Geboes K; Löfberg R
Anticancer Res; 2005; 25(6C):4393-7. PubMed ID: 16334114
[TBL] [Abstract][Full Text] [Related]
27. Colorectal neoplasia in ulcerative colitis-recent advances.
Wong NA; Harrison DJ
Histopathology; 2001 Sep; 39(3):221-34. PubMed ID: 11532032
[TBL] [Abstract][Full Text] [Related]
28. [Colorectal tumor evolution in inflammatory bowel disease : Dynamics of genomic alterations and potential molecular markers to predict malignant progression].
Hirsch D
Pathologe; 2019 Dec; 40(Suppl 3):232-238. PubMed ID: 31811372
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite instability is uncommon in intestinal mucosa of patients with Crohn's disease.
Noffsinger A; Kretschmer S; Belli J; Fogt F; Fenoglio-Preiser C
Dig Dis Sci; 2000 Feb; 45(2):378-84. PubMed ID: 10711455
[TBL] [Abstract][Full Text] [Related]
30. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
31. Carcinogenesis in inflammatory bowel disease.
Herszenyi L; Miheller P; Tulassay Z
Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
[TBL] [Abstract][Full Text] [Related]
32. Colorectal adenocarcinoma in Crohn's disease: a retrospective histologic study.
Rubio CA; Befrits R
Dis Colon Rectum; 1997 Sep; 40(9):1072-8. PubMed ID: 9293938
[TBL] [Abstract][Full Text] [Related]
33. Genomic characterization of colitis-associated colorectal cancer.
Kameyama H; Nagahashi M; Shimada Y; Tajima Y; Ichikawa H; Nakano M; Sakata J; Kobayashi T; Narayanan S; Takabe K; Wakai T
World J Surg Oncol; 2018 Jul; 16(1):121. PubMed ID: 29966533
[TBL] [Abstract][Full Text] [Related]
34. Genomic Landscape of Early-stage Colorectal Neoplasia Developing From the Ulcerative Colitis Mucosa in the Japanese Population.
Matsumoto K; Urabe Y; Oka S; Inagaki K; Tanaka H; Yuge R; Hayashi R; Kitadai Y; Arihiro K; Shimamoto F; Tanaka S; Chayama K
Inflamm Bowel Dis; 2021 Apr; 27(5):686-696. PubMed ID: 33089869
[TBL] [Abstract][Full Text] [Related]
35. Interval colorectal cancers in inflammatory bowel disease: the grim statistics and true stories.
Sanduleanu S; Rutter MD
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):337-48. PubMed ID: 24975525
[TBL] [Abstract][Full Text] [Related]
36. Chronic ulcerative colitis and colorectal cancer.
Rogler G
Cancer Lett; 2014 Apr; 345(2):235-41. PubMed ID: 23941831
[TBL] [Abstract][Full Text] [Related]
37. Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
Ross JS; Fakih M; Ali SM; Elvin JA; Schrock AB; Suh J; Vergilio JA; Ramkissoon S; Severson E; Daniel S; Fabrizio D; Frampton G; Sun J; Miller VA; Stephens PJ; Gay LM
Cancer; 2018 Apr; 124(7):1358-1373. PubMed ID: 29338072
[TBL] [Abstract][Full Text] [Related]
38. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J
BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282
[TBL] [Abstract][Full Text] [Related]
39. Multiclonal colorectal cancers with divergent histomorphological features and RAS mutations: one cancer or separate cancers?
Lin MT; Zheng G; Tseng LH; Zhang P; Ling H; Azad N; Gocke CD; Montgomery E; Eshleman JR
Hum Pathol; 2020 Apr; 98():120-128. PubMed ID: 32171651
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
